11.5SEK
172.20 MSEK
1.59 BSEK
11.19 M
About MEDCAP AB
Sector
Industry
Headquarters
Stockholm
Website
Employees (FY)
514
Founded
2001
ISIN
SE0009160872
FIGI
BBG000QRS5S9
MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. It operates through the MedTech and Specialty Pharma segments. The firm's portfolio includes: Abilia, Cardiolex Medical, Multi-ply, Inpac, and Unimedic. The company was founded in 2001 and is headquartered in Stockholm, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of MCAP is 397.5 SEK — it has decreased by 1.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange MEDCAP AB stocks are traded under the ticker MCAP.
MEDCAP AB is going to release the next earnings report on May 3, 2024. Keep track of upcoming events with our Earnings Calendar.
MCAP stock is 2.39% volatile and has beta coefficient of 0.71. Check out the list of the most volatile stocks — is MEDCAP AB there?
One year price forecast for MEDCAP AB has a max estimate of 405.0 SEK and a min estimate of 405.0 SEK.
MCAP earnings for the last quarter are 2.85 SEK whereas the estimation was 2.54 SEK which accounts for 12.20% surprise. Estimated earnings for the next quarter are 4.20 SEK. See more details about MEDCAP AB earnings.
MEDCAP AB revenue for the last quarter amounts to 323.00 M SEK despite the estimated figure of 271.00 M SEK. In the next quarter revenue is expected to reach 454.60 M SEK.
Yes, you can track MEDCAP AB financials in yearly and quarterly reports right on TradingView.
MCAP stock has fallen by 3.87% compared to the previous week, the month change is a 6.00% rise, over the last year MEDCAP AB has showed a 47.22% increase.
MCAP net income for the last quarter is 62.20 M SEK, while the quarter before that showed 38.30 M SEK of net income which accounts for 62.40% change. Track more MEDCAP AB financial stats to get the full picture.
Today MEDCAP AB has the market capitalization of 5.96 B, it has increased by 9.61% over the last week.
No, MCAP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, MCAP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MEDCAP AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 514.00 employees. See our rating of the largest employees — is MEDCAP AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MEDCAP AB technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MEDCAP AB stock shows the buy signal. See more of MEDCAP AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on MEDCAP AB future price: according to them, MCAP price has a max estimate of 405.00 SEK and a min estimate of 405.00 SEK. Read a more detailed MEDCAP AB forecast: see what analysts think of MEDCAP AB and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MEDCAP AB EBITDA is 330.50 M SEK, and current EBITDA margin is 20.51%. See more stats in MEDCAP AB financial statements.